The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation

Sixty five patients (18–31 years) who had received allogeneic haematopoietic stem cell transplantation (3–27 years from HSCT) were evaluated for the tolerance and immunogenicity of the COVID-19 mRNA BNT163b2 vaccine. Methods: Patients were vaccinated with two doses at 5 weeks interval. After each do...

Descripción completa

Detalles Bibliográficos
Autores principales: Matkowska-Kocjan, Agnieszka, Owoc-Lempach, Joanna, Chruszcz, Joanna, Kuźnik, Edwin, Szenborn, Filip, Jurczenko, Lidia, Wójcik, Marta, Banyś, Dorota, Szenborn, Leszek, Ussowicz, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539173/
https://www.ncbi.nlm.nih.gov/pubmed/34696317
http://dx.doi.org/10.3390/vaccines9101209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539173/
https://www.ncbi.nlm.nih.gov/pubmed/34696317
http://dx.doi.org/10.3390/vaccines9101209

Ejemplares similares